Radiation can absolutely cause hair loss, but only when it is delivered to or near an area where hair grows. The scalp is by far the most common site affected, and the medical term for it is radiotherapy-induced alopecia. Whether the hair loss is temporary or permanent depends heavily on the dose: lower doses tend to cause shedding that reverses within a few months, while higher doses can destroy hair follicles outright and leave patches that never fill back in. The biology behind this vulnerability, and the efforts to work around it, turn out to be surprisingly complex.
Why Hair Follicles Are So Sensitive
Hair follicles rank among the most rapidly dividing structures in the human body. Cells in a growing follicle multiply fast, which is exactly what makes them good at producing hair and exactly what makes them a target for ionizing radiation. Radiation damages DNA most effectively in cells that are actively dividing, so the follicle’s own growth engine is also its weakness. When radiation hits a follicle that is in its active growth phase, it can trigger cell death and a premature shutdown of hair production.
Follicles do not all respond the same way. Researchers have identified two distinct damage pathways: in one, the follicle enters a kind of stunted, abnormal growth state before the hair shaft breaks off or falls out; in the other, the follicle is pushed prematurely into a resting or regression phase, halting growth altogether.1Journal of Investigative Dermatology. Clinical Pathobiology of Radiotherapy-Induced Alopecia: A Guide toward More Effective Prevention and Hair Follicle Repair Which pathway dominates depends on the radiation dose, how quickly it is delivered, and where the individual follicle sits in its life cycle at the time of treatment.
That life-cycle detail matters more than you might expect. Hair follicles cycle between a growth phase, a brief transition, and a resting phase. Follicles in the resting phase are far more resistant to radiation damage. In animal studies, resting-phase follicles exposed to a moderate dose showed only a temporary pause in cell activity and then went on to produce normal hair, while growth-phase follicles exposed to the same dose suffered cell death and a significant loss of stem cells.2Advances in Radiation Oncology. FGF18 signaling in the hair cycle resting phase determines radioresistance of hair follicles by arresting hair cycling Since the vast majority of scalp follicles are in the growth phase at any given time, most of the scalp is vulnerable whenever radiation is aimed at the head.
How Much Radiation It Takes
There is not a single magic number that separates “you keep your hair” from “you lose it.” Different treatment schedules, beam types, and patient factors all shift the threshold. That said, research has converged on some useful ranges.
For temporary hair loss during conventional cranial radiation, a prospective study found that scalp areas receiving roughly 22 Gy or more were likely to show transient shedding, while permanent loss required considerably higher doses, around 37 Gy when measured across the whole scalp.3PLOS ONE. Scalp dose analysis for transient and permanent alopecia following conventional cranial irradiation using Image Guided Radiotherapy (IGRT): A prospective study At the specific patches where hair was lost permanently, localized doses were even higher, closer to 50 Gy.
Those numbers line up with a separate study modeling alopecia prediction, which found that fractionated radiation schedules could predict visible hair loss at about 12.6 Gy total for conventional fractionation schemes, with accuracy reaching about 90 percent across nearly 150 patients.4PubMed Central. Pre-treatment visualization of predicted radiation-induced acute alopecia in brain tumour patients The variation between studies reflects the fact that “dose” is not one-size-fits-all: fraction size, total treatment duration, and beam energy all influence how much damage the follicles ultimately absorb.
A useful clinical benchmark comes from a study examining the probability of more severe alopecia as scalp dose climbs. The researchers found that for every additional gray of scalp dose, the odds of significant hair loss increased by about 16 percent, and the dose at which a patient had a coin-flip chance of substantial alopecia was around 36 Gy.5JAMA Dermatology. Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer For severe permanent alopecia specifically, a study in pediatric patients treated with whole-brain and spinal radiation identified an optimal cutoff near 20 Gy, above which the risk of lasting hair loss jumped sharply.6International Journal of Radiation Oncology, Biology, Physics. A Scalp Dose Threshold for Preventing Permanent Alopecia in Scalp-Avoidance Whole-Brain Irradiation With Volumetric Modulated Arc Radiation Therapy for Pediatric Patients With Medulloblastomas
Temporary Versus Permanent Hair Loss
Most people treated with radiation to the head experience temporary thinning or patchy loss that begins a few weeks into treatment. At lower doses, the follicle’s stem cell reservoir survives the hit, and once the radiation course ends, those stem cells can rebuild the follicle and restart hair growth. Regrowth typically begins within a couple of months after treatment wraps up, though it sometimes takes longer.
Permanent alopecia is a different situation. When radiation doses are high enough, the damage extends beyond the actively dividing cells and wipes out the stem cell population that the follicle needs to regenerate. What remains is often scarred tissue: the skin becomes fibrotic and the follicle structures are replaced by scar-like collagen.7PubMed. Cicatricial alopecia secondary to radiation therapy: case report and review of the literature Once that scarring sets in, no amount of waiting will bring the hair back in those areas. This is sometimes called cicatricial (scarring) alopecia, and it can be confirmed by biopsy showing that the follicle architecture has been replaced entirely.
Between these two extremes there is a gray zone. Some patients end up with follicle miniaturization, where the follicles survive but produce thinner, finer, or slower-growing hairs than before treatment. These miniaturized follicles can persist for years, leaving patches that look sparse rather than fully bald.1Journal of Investigative Dermatology. Clinical Pathobiology of Radiotherapy-Induced Alopecia: A Guide toward More Effective Prevention and Hair Follicle Repair This middle-ground outcome is one reason radiation-induced hair loss can be unpredictable even when doctors know the exact dose delivered.
Children Are Especially Vulnerable
Pediatric patients treated with cranial radiation face a notably higher risk of lasting hair loss compared to adults receiving similar doses. Part of this has to do with the types of tumors that require whole-brain or craniospinal radiation in children, which often demand higher total doses over larger treatment fields. Medulloblastoma, one of the most common pediatric brain cancers, frequently calls for radiation to the entire brain and spinal cord.
A cohort study of childhood medulloblastoma survivors found that high-dose craniospinal irradiation was an independent risk factor for permanent alopecia, affecting both the whole scalp and, in particular, the nape of the neck.8PubMed Central. High dose craniospinal irradiation as independent risk factor of permanent alopecia in childhood medulloblastoma survivors: cohort study and literature review The nape region is especially susceptible because it sits directly in the path of spinal radiation fields, receiving a concentrated dose.
Dose thresholds for permanent hair loss in children may be somewhat lower than in adults, particularly when chemotherapy is given at the same time. One study of pediatric medulloblastoma patients treated with proton radiation found that permanent alopecia correlated with a craniospinal dose of about 21 Gy in children also receiving intensive chemotherapy, compared to around 30 Gy in children on standard chemotherapy regimens.9PubMed Central. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation The chemotherapy appears to sensitize the follicles, lowering the radiation dose needed to cause irreversible damage. For families navigating a child’s cancer treatment, this interaction between therapies is worth discussing with the radiation oncologist.
Modern Techniques to Reduce Hair Loss
Radiation oncologists have developed several strategies to limit the dose that reaches the scalp, even when the brain itself needs a full therapeutic dose. The basic idea is to shape the radiation beams so that the tumor and surrounding brain tissue get the intended dose while the hair-bearing skin is spared as much as possible.
One well-studied approach uses intensity-modulated radiotherapy (IMRT), which breaks the radiation beam into many small segments that can be individually adjusted. A planning study showed that a nine-field IMRT design with scalp-sparing constraints could reduce the percentage of scalp receiving moderate-to-high doses by roughly 35 to 46 percent compared to traditional treatment plans, while still delivering adequate coverage to the brain.10PubMed Central. Dose Reduction to the Scalp with Hippocampal Sparing Is Achievable with Intensity Modulated Radiotherapy
A related technique is hippocampal-sparing whole-brain radiation, originally designed to protect memory function by shielding a structure deep in the brain. An unexpected bonus: because the beam arrangement required to avoid the hippocampus also reshapes how radiation distributes across the skull, it can significantly lower scalp dose as well. One analysis found that hippocampal-sparing plans delivered a meaningfully lower mean dose to the hair-bearing scalp and effectively prevented alopecia compared to conventional whole-brain radiation.11PubMed Central. Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy
Volumetric arc therapy (VMAT), where the radiation machine rotates around the patient while continuously modulating the beam, has also been tested. In a phase II trial of VMAT-based whole-brain radiation, the average dose to the hair follicle region was reduced by about 37 percent compared to the prescribed brain dose. Despite this reduction, the trial was stopped early because hair loss remained significant for most patients, suggesting that dose reduction alone may not be enough when the entire brain needs radiation.12PubMed Central. Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trial The technology is promising but not yet a guaranteed solution, particularly for whole-brain treatments where the margins for sparing are slim.
What Happens When Hair Grows Back
When radiation-induced hair loss is temporary, regrowth usually begins within two to three months after the last treatment session. But the hair that comes back is not always the same as the hair that fell out. Changes in color, texture, and curl pattern are reported frequently. Some patients find their hair grows back noticeably darker or lighter, curlier than before, or with a wiry texture. The exact mechanisms behind these changes are not well understood, but they likely involve altered signaling in the regenerating follicle and changes in the pigment-producing cells at the follicle’s base.13PubMed Central. Hair disorders in patients with cancer
For some people, these texture changes are temporary and the hair eventually returns to something close to its pre-treatment character. For others, the changes persist indefinitely. There is no reliable way to predict ahead of time whose hair will grow back differently. It is worth knowing that these changes, while cosmetically noticeable, generally indicate that the follicles are alive and functioning, which is the more important outcome from a recovery standpoint.
Radiation That Does Not Hit the Scalp
If you are receiving radiation to the chest, abdomen, pelvis, or an extremity, you will not lose the hair on your head. Radiation-induced hair loss is local: it only occurs in the area being treated. Chest radiation might thin body hair in the treatment zone, and pelvic radiation can affect pubic hair, but neither will touch the scalp. This is a common point of confusion, because chemotherapy-induced hair loss tends to be widespread and affects the entire body. Radiation is fundamentally different in this regard.
Even systemic radiation delivered through the bloodstream, such as certain radiopharmaceutical therapies used for neuroendocrine tumors, tends to produce only mild and reversible hair thinning rather than the dramatic shedding seen with focused cranial radiation. In patients treated with a common radiolabeled therapy, mild hair loss was observed during treatment but hair growth returned to normal within three to six months of the final dose.14Best Practice & Research Clinical Gastroenterology. Peptide receptor radionuclide therapy The doses that reach the scalp through the bloodstream are simply too low to cause permanent follicle destruction.
The Emotional Weight of Radiation Hair Loss
Hair loss from radiation occupies an awkward space in cancer care. It receives less attention than chemotherapy-induced hair loss, partly because it is localized rather than total, and partly because the focus of radiation treatment is often on the brain tumor itself, where survival takes priority. But for patients who end up with permanent bald patches, the psychological burden can be substantial and long-lasting.
A study evaluating quality of life in patients with persistent radiation-induced alopecia found that the emotional impact was the most affected domain, scoring worse than functioning, stigmatization, or physical symptoms on a validated hair-related quality-of-life questionnaire.5JAMA Dermatology. Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer Patients reported feeling distress about their appearance and a sense of being marked by their illness even years after treatment ended.
The impact is especially pronounced in childhood cancer survivors. A large survivorship study found that hair loss increased the risk of anxiety by about 60 percent and raised the risk of emotional limitations by roughly a quarter compared to survivors without hair loss, even after accounting for the effects of cranial radiation itself and other factors like age and sex.15PubMed Central. Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor study For children and adolescents still forming their identities, permanent patches of hair loss can shape self-image in ways that persist well into adulthood.
Does Scalp Care During Treatment Make a Difference?
Patients starting cranial radiation often receive advice about how to treat their scalp during the process: wash gently, avoid harsh products, limit brushing, sometimes even restrict how often they shampoo. The logic is intuitive enough, since the scalp skin is being irradiated, and being gentle with it seems like common sense. The evidence, though, is less clear-cut than the advice suggests.
A randomized trial of over 100 patients starting cranial radiation divided them into groups with different washing instructions. The patients who were told to restrict shampooing did wash less often, but when researchers compared the two groups on measured skin reactions, there were no significant differences.16PubMed. Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial This is a single older trial, and it measured skin reaction rather than hair loss directly, so it should not be taken as the last word. But it does suggest that strict washing restrictions may cause unnecessary inconvenience without meaningfully protecting the scalp or hair. Keeping the skin clean and comfortable is reasonable; avoiding hygiene out of fear of making things worse is probably not helping.
A Cautionary Historical Chapter
Before antifungal medications existed, doctors sometimes used low-dose X-rays to deliberately make children’s hair fall out as a treatment for scalp ringworm. The idea was that shedding the infected hair would clear the fungal infection. Thousands of children received this treatment through the mid-twentieth century. A long-term follow-up of over 2,200 children who had X-ray epilation for ringworm tracked cancer incidence for up to 50 years, comparing them with a control group who received only topical treatments.17Radiation Research. Skin Cancer after X-Ray Treatment for Scalp Ringworm The irradiated children had elevated rates of skin cancer and other tumors decades later. This episode underscored a principle that now guides radiation oncology: even modest doses to the scalp carry long-term biological consequences beyond hair loss, which is part of why modern treatment planning works so hard to minimize unnecessary scalp exposure.
The ringworm era also demonstrated something about dose and reversibility that remains relevant. The X-ray doses used were relatively low, just enough to trigger temporary shedding, and most children’s hair did grow back. But some developed patchy permanent loss years later, a delayed effect that was poorly understood at the time. Modern research on follicle miniaturization and late stem cell depletion helps explain why radiation damage to hair can sometimes declare itself long after the initial exposure, making follow-up monitoring worthwhile for anyone who has received meaningful scalp doses.